News Image

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Provided By GlobeNewswire

Last update: Aug 5, 2025

SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its second quarter 2025 financial results after the U.S. financial markets close on Tuesday, August 12, 2025. Journey Medical management will conduct a conference call and audio webcast on Tuesday, August 12, 2025 at 4:30 p.m. ET.

Read more at globenewswire.com

JOURNEY MEDICAL CORP

NASDAQ:DERM (8/15/2025, 8:15:37 PM)

After market: 6.3259 -0.62 (-8.98%)

6.95

-0.31 (-4.27%)


FORTRESS BIOTECH INC

NASDAQ:FBIO (8/15/2025, 8:18:30 PM)

After market: 2.17 +0.05 (+2.36%)

2.12

+0.16 (+8.16%)



Find more stocks in the Stock Screener

DERM Latest News and Analysis

Follow ChartMill for more